Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELD™ vaccine in SARS-CoV-2 seronegative young Indian adults.
Rakshit S, Adiga V, Ahmed A, Parthiban C, Kumar NC, Dwarkanath P, Shivalingaiah S, Rao S, D'Souza G, Dias M, Maguire TJA, Doores K, Dasgupta P, Babji S, Ottenhoff THM, Stuart KD, De Rosa S, McElrath MJ, Vyakarnam A. Rakshit S, et al. Res Sq [Preprint]. 2022 Mar 2:rs.3.rs-1395683. doi: 10.21203/rs.3.rs-1395683/v1. Res Sq. 2022. PMID: 35262071 Free PMC article. Preprint.
Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.
Asokan MS, Joan RF, Babji S, Dayma G, Nadukkandy P, Subrahmanyam V, Pandey A, Malagi G, Arya P, Mahajan V, Bhavikatti J, Pawar K, Thorat A, Shah P, Goud RB, Roy B, Rajukutty S, Immanuel S, Agarwal D, Saha S, Shivaraj A, Panikulam P, Shome R, Gulzar SE, Sharma AU, Naik A, Talashi S, Belekar M, Yadav R, Khude P, V M, Shivalingaiah S, Deshmukh U, Bhise C, Joshi M, Inbaraj LR, Chandrasingh S, Ghose A, Jamora C, Karumbati AS, Sundaramurthy V, Johnson A, Ramesh N, Chetan N, Parthiban C, Ahmed A, Rakshit S, Adiga V, D'souza G, Rale V, George CE, John J, Kawade A, Chaturvedi A, Raghunathan A, Dias M, Bhosale A, Raghu P, Shashidhara LS, Vyakarnam A, Bal V, Kang G, Mayor S. Asokan MS, et al. Lancet Reg Health Southeast Asia. 2024 Feb 27;22:100361. doi: 10.1016/j.lansea.2024.100361. eCollection 2024 Mar. Lancet Reg Health Southeast Asia. 2024. PMID: 38482152 Free PMC article.
Immune profiling reveals umbilical cord blood mononuclear cells from South India display an IL-8 dominant, CXCL-10 deficient polyfunctional monocyte response to pathogen-associated molecular patterns that is distinct from adult blood cells.
Adiga V, Bindhu H, Ahmed A, Chetan Kumar N, Tripathi H, D'Souza G, Dias M, Shivalingaiah S, Rao S, K N S, Hawrylowicz C, Dwarkanath P, Vyakarnam A. Adiga V, et al. Clin Exp Immunol. 2024 Aug 9;217(3):263-278. doi: 10.1093/cei/uxae034. Clin Exp Immunol. 2024. PMID: 38695079 Free PMC article.
PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, double-blind, three-arm placebo-controlled trial.
Singh M, Mehendale S, Guleria R, Sarin R, Tripathy S, Gangakhedkar RR, Katoch K, Pandey RM, Panda S, Pati S, Mohapatra PR, Joshi S, Narasimhaiah S, Kodan P, Bhaskar S, Rani R, Khan AM, Swaminathan S; PreVenTB Trial Team. Singh M, et al. BMJ Open. 2024 Aug 31;14(8):e082916. doi: 10.1136/bmjopen-2023-082916. BMJ Open. 2024. PMID: 39645271 Free article.
Pediatric erythromelalgia from multidisciplinary perspectives: a scoping review.
Ocay DD, Graziano Maloney M, D'Souza G, Brownstein CA, Clinch J, Davis DM, De Ranieri D, Donado C, Halpin M, Kattail D, Lee BH, Lobo K, Ravetti D, Sandroni P, Stinson JN, Tham SW, Walco GA, Walker SM, Yu TW, Berde CB. Ocay DD, et al. Among authors: d souza g. Pediatr Res. 2025 Jan 16. doi: 10.1038/s41390-025-03817-4. Online ahead of print. Pediatr Res. 2025. PMID: 39821136 Review.
Brief Report: Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors and the Risk of Cancer Among People With HIV.
Coburn SB, Pimentel N, Leyden W, Kitahata M, Moore RD, Althoff KN, Gill MJ, Lang R, Horberg MA, D'Souza G, Hussain SK, Dubrow R, Novak RM, Rabkin CS, Park LS, Sterling TR, Neugebauer RS, Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS. Coburn SB, et al. Among authors: d souza g. J Acquir Immune Defic Syndr. 2024 Aug;96(4):393-398. doi: 10.1097/QAI.0000000000003436. J Acquir Immune Defic Syndr. 2024. PMID: 39720558
514 results